ReportWire

Tag: University College London

  • Air pollution from oil and gas causes 90,000 premature US deaths each year, says new study

    [ad_1]

    Air pollution from oil and gas causes more than 90,000 premature deaths and sickens hundreds of thousands of people across the US each year, a new study shows, with disproportionately high impacts on communities of color.

    More than 10,000 annual pre-term births are attributable to fine particulate matter from oil and gas, the authors found, also linking 216,000 annual childhood-onset asthma cases to the sector’s nitrogen dioxide emissions and 1,610 annual lifetime cancer cases to its hazardous air pollutants.

    The highest number of impacts are seen in California, Texas, New York, Pennsylvania and New Jersey, while the per-capita incidences are highest in New Jersey, Washington DC, New York, California and Maryland.

    Related: Trump-fueled gas boom has Gulf coast communities on edge: ‘We will keep fighting’

    The analysis by researchers at University College London and the Stockholm Environment Institute is the first to examine the health impacts – and unequal health burdens – caused by every stage of the oil and gas supply chain, from exploration to end use.

    “We’ve long known that these communities are exposed to such levels of inequitable exposure as well as health burden,” said Karn Vohra, a postdoctoral research fellow in geography at University College London, who led the paper. “We were able to just put numbers to what that looks like.”

    While Indigenous and Hispanic populations are most affected by pollution from exploration, extraction, transportation and storage, Black and Asian populations are most affected by emissions from processing, refining, manufacturing, distribution and usage.

    Though the latter set of activities is responsible for less air pollution overall than the former, the study shows they cause the most unequal health burden, with impacts concentrated in majority-Black areas including southern Louisiana’s “Cancer Alley” and eastern Texas.

    “What makes the study so valuable is how it dissects health impacts across the whole life cycle of oil and gas – from where it comes out of the ground to where it is combusted,” Timothy Donaghy, research director for the environmental group Greenpeace USA and author of previous research on the racially uneven burdens of fossil fuel pollution. “As many studies have found before, these health burdens are not shared equally – a prime example of fossil fuel racism in action.”

    For the analysis, published in Science Advances on Friday, the authors developed an inventory of each stage of oil and gas production and use, with data from the federal government and the University of Colorado Boulder. They plugged that data into a computer model to track pollution from each source, and used epidemiological and health data to track the adverse impacts of those emissions.

    These disproportionate impacts are not inexplicable; rather, they are attributable to historic policies such as redlining – a discriminatory mortgage appraisal practice used after the Great Depression by the US government – and high rates of permitting for oil and gas processing plants in close proximity to Black communities.

    Oil and gas are responsible for a major share of all air pollution-attributable health impacts in the US, the authors also found: one in five pre-term births and adult deaths linked to fine particulate pollution are from the sector, the authors found, while a stunning 90% of new childhood asthma cases tied to nitrogen dioxide pollution are from oil and gas.

    The study is based on data from 2017, the most recent year of complete data available. Between that year and 2023, US oil and gas production has increased by 40% and consumption by 8%, meaning the estimates are probably highly conservative.

    The research comes as the Trump administration works to boost fossil fuel production and suppress renewable energy production.

    “Given the reckless deregulation being pushed by Trump’s EPA and the president’s call to ‘drill, baby, drill’, this new study should be a flashing red warning light for the nation,” said Donaghy.

    Eloise Marais, a University College London professor of geography and study co-author, said she hoped the study was “picked up by the kinds of community leaders and advocacy groups that are pushing for exposure to cleaner air”.

    “If there was a move away from reliance on oil and gas, we would experience the climate change benefits 50, 100, 200 years from today because the greenhouse gases stay in the atmosphere so long,” she said. “But communities would experience the health benefits immediately.”

    [ad_2]

    Source link

  • Megyn Kelly Reveals What’s Really Wrong With Kamala Harris – ‘She Thinks She’s Rush Limbaugh’

    Megyn Kelly Reveals What’s Really Wrong With Kamala Harris – ‘She Thinks She’s Rush Limbaugh’

    [ad_1]

    Opinion

    Source YouTube: Megyn Kelly Show, CBS Mornings

    The former Fox News host Megyn Kelly spoke out this week to reveal what’s really wrong with Vice President Kamala Harris, saying that she talks to people “like they’re on the short bus.”

    Kelly Eviscerates Harris

    During Thursday’s episode of her eponymous SiriusXM talk show, Kelly played a clip from Harris’ appearance on “The View” earlier this week in which she said that she is “scared as heck” of Donald Trump being reelected.

    “She thinks she’s Rush Limbaugh. She’s not. It’s so obvious,” Kelly said in response. “She tries to explain things to people all the time, as though she’s talking to a 2 year old. And look, I talk to my audience about complex things all the time, and I never assume anybody understands a complex thing. I always give a couple lines of explanation because people are living their lives and they’re not following politics day and night like I am. But I don’t treat them like they’re idiots.”

    “I have a respect for my audience’s intelligence that they deserve because I talk to my audience,” Kelly continued. “They call in all the time on SiriusXM, they write in at MegynKelly.com. She talks to the people listening to her like she thinks they’re on the short bus. Forgive me, but she does.”

    Not stopping there, Kelly went on to say that she feels “insulted” by the way that Harris speaks.

    “All I feel is insulted. My intelligence is insulted. I’m bored by you. I’m offended by you,” Kelly said. “The thing is, it almost makes me think of Oprah. So Oprah actually was full of profundities when she did that show. But back in the day when I was young and in law school and you turn on ‘The Oprah Winfrey Show,’ you would hear something. She was the one we got the ‘aha moment’ from.”

    “She would have this little catchphrase where you’re like, ‘Oh, yeah, that’s something to think about,’ and her team would set it to music and they’d slow down the interaction, and you’d be moved,” Kelly added. “You’d think, ‘Oh, I feel inspired.’ She thinks she’s Oprah. She thinks we’re going to add a little twinkly music. I’m going to say it like this, and even though it’s total inanity, it’s going to move people.”

    Check out Kelly’s full comments on this in the video below.

    Related: Kamala Harris Admits She’s ‘Scared As Heck’ Of Trump

    This isn’t the first time that Kelly has blasted Harris publicly. In July of last year, she ripped Harris as a “moron” after saying that she gave her “the benefit of the doubt” at first.

    “I did not think she was an idiot. I now think she’s a moron. She’s not that smart. Forgive me, I’m still one of those people who gets wooed by titles like, ‘She was the attorney general in state of California.’ You know, how dumb could she be? Like, dumb. The answer is very, very dumb,” Kelly said, according to OK! Magazine. “And I come to that conclusion just with my own eyes and ears from watching and listening to her. She cannot put two sentences together.”

    “She’s just not a smart person, and it concerns me because that’s all we have in line at the Democratic side. And as [Donald] Trump’s numbers continue to go up and up and up – and I realize some of the polls are showing him beating Joe Biden now in a hypothetical matchup – he’s still very vulnerable,” she added. “He did not win in 2020 and it looks like it’s gonna be the same matchup, and honestly, Joe Biden’s knocking on the Grim Reaper’s door, and she could be the President of the United States in the next six years by default, if things go in a dark and upsetting way. I’m concerned.”

    Related: Kamala Harris Humiliated As Radio Host Charlamagne Tha God Admits He Regrets Backing Her

    Harris Is More Unpopular Than Ever

    Millions of Americans will agree with Kelly’s assessment of Harris, whose approval rating fell from 41.7 percent to 36.3 percent last year while her disapproval increased from 51.7 percent to 53.7 percent, according to analysis by polling website 538. Thomas Gift, who heads up the Centre on U.S. Politics at University College London, told Newsweek last month that Harris’ unpopularity “could end up being a difference-maker” in the 2024 presidential election.

    “To realize just how unpopular Kamala Harris is, you have to keep in mind the historical significance of it all,” Gift said. “No one in her position has had this low of favorabilities in a first term since Dan Quayle. That’s saying something. So it’s no surprise, especially with Biden’s age, that Republicans keep hammering home a simple point: a vote for Biden is a vote for Harris.

    “While it’s usually the top of the ticket that drives voting, and that will be true again in 2024, Harris’ abysmal popularity will matter on the margins,” he added. “And with next year’s election poised to be close, those margins could end up being a difference-maker.”

    What do you think about Kelly’s comments on Harris? Let us know in the comments section.

    Now is the time to support and share the sources you trust.
    The Political Insider ranks #3 on Feedspot’s “100 Best Political Blogs and Websites.”

    An Ivy leaguer, proud conservative millennial, history lover, writer, and lifelong New Englander, James specializes in the intersection of… More about James Conrad

    FREE NEWS ALERTS

    Subscribe to receive the most important stories delivered straight to your inbox. Your subscription helps protect independent media.



    By subscribing, you agree to receive emails from ThePoliticalInsider.com and that you’ve read and agree to our Privacy policy and to our terms and conditions.

    FREE NEWS ALERTS

    [ad_2]

    James Conrad

    Source link

  • Kamala Harris Admits She’s ‘Scared As Heck’ Of Trump

    Kamala Harris Admits She’s ‘Scared As Heck’ Of Trump

    [ad_1]

    Opinion

    Source YouTube: The View, The Independent

    While appearing on the ABC talk show “The View” on Wednesday morning, Vice President Kamala Harris admitted to the liberal co-host Joy Behar that she is “scared as heck” of the former President Donald Trump ahead of this year’s presidential election.

    Harris Is ‘Scared As Heck’

    At one point in the interview, Behar asked Harris about concerns over the state of Joe Biden’s presidential campaign.

    “President Obama reportedly has said that he thinks the Biden campaign is too complacent when it comes to Trump,” she began. “Representative Jim Clyburn has said the campaign isn’t breaking through the MAGA wall. Michelle Obama says she’s terrified, as we are, about the potential outcome of the election.”

    “Now, are you scared?” Behar asked. “What could happen if Trump ever became, God forbid, president again? And what are you going to do to stop the crazies?”

    “I am scared as heck!” Harris bluntly responded. “Which is why I’m traveling our country.”

    “You know, there’s an old saying that there are only two ways to run for office: Either without an opponent or scared,” she continued. “So on all of those points, yes, we should ALL be scared.”

    Related: Kamala Harris Humiliated As Radio Host Charlamagne Tha God Admits He Regrets Backing Her

    ‘We Got To Earn Reelection’

    Harris went on to bring the interview back to the issue of women and children.

    “But as we know, and certainly this is a table of very powerful women,” she said. “We don’t run away from something when we’re scared. We fight back against it. Right. Yeah. So many of us know when we are scared for the future of our children, do we then stay in bed with the covers over our head? Nope. No we can’t. We cannot. We cannot. And this is where this election requires brightly that President Biden and I and and all of us who are part of this administration, we got to earn reelection.”

    “There is no question,” she concluded. “We got to be on the road. Listen, since the in the last two weeks I’ve been to Georgia, I’ve been to Nevada, I’ve been to North Carolina, I’ve been to South Carolina twice. In the first two weeks of this year, I will be out on the road. We have to earn the reelect and we have to communicate what we have achieved, and that is going to be one of our big challenges. We’ve done a lot of good work. We need to let people know who bring it to them.”

    Check out this full interview in the video below.

    Related: Kamala Harris Refuses To Cite A Single Abortion Restriction She Supports

    Harris’ Unpopularity ‘Could End Up Being A Difference-Maker’

    Harris has good reason to be “scared as heck,” as her approval rating fell from 41.7 percent to 36.3 percent last year while her disapproval increased from 51.7 percent to 53.7 percent, according to analysis by polling website 538. Thomas Gift, who heads up the Centre on U.S. Politics at University College London, told Newsweek last month that Harris’ unpopularity “could end up being a difference-maker” in the 2024 presidential election.

     “To realize just how unpopular Kamala Harris is, you have to keep in mind the historical significance of it all,” Gift said. “No one in her position has had this low of favorabilities in a first term since Dan Quayle. That’s saying something. So it’s no surprise, especially with Biden’s age, that Republicans keep hammering home a simple point: a vote for Biden is a vote for Harris.

    “While it’s usually the top of the ticket that drives voting, and that will be true again in 2024, Harris’ abysmal popularity will matter on the margins,” he added. “And with next year’s election poised to be close, those margins could end up being a difference-maker.”

    What do you think about this? Let us know in the comments section.

    Now is the time to support and share the sources you trust.
    The Political Insider ranks #3 on Feedspot’s “100 Best Political Blogs and Websites.”

    An Ivy leaguer, proud conservative millennial, history lover, writer, and lifelong New Englander, James specializes in the intersection of… More about James Conrad

    FREE NEWS ALERTS

    Subscribe to receive the most important stories delivered straight to your inbox. Your subscription helps protect independent media.



    By subscribing, you agree to receive emails from ThePoliticalInsider.com and that you’ve read and agree to our Privacy policy and to our terms and conditions.

    FREE NEWS ALERTS

    [ad_2]

    James Conrad

    Source link

  • Artificial intelligence helps to simplify lung cancer risk prediction

    Artificial intelligence helps to simplify lung cancer risk prediction

    [ad_1]

    Newswise — Machine learning models to identify the simplest way to screen for lung cancer have been developed by researchers from UCL and the University of Cambridge, bringing personalised screening one step closer.

    The model was found to be as good or better at predicting an individual’s risk of getting lung cancer within five years compared to the best risk models available, and was able to do so using just a quarter of the information needed.

    Lung cancer is the most common cause of cancer death worldwide, with poor survival in the absence of early detection. It is estimated that there were 1.8 million lung cancer deaths globally in 20201.

    Screening for lung cancer amongst those at high-risk could reduce lung cancer-specific mortality by 20-24% amongst those screened, but the ideal way to determine if someone is high-risk remains uncertain and existing approaches are resource intensive.

    The UK is currently planning a national screening programme for lung cancer, which will include people aged 55-74 who have ever smoked, using a risk model based on 17 questions. This information is complex and time-consuming to gather and will require a 50-100 person-strong call centre to collect the data from one million people.

    In this study, researchers from UCL and the University of Cambridge used data from the UK Biobank and US National Lung Screening Trial to develop models to simplify the prediction of a person getting lung cancer within the next five years.

    The team used the datasets to experiment with over 60 different machine learning pipelines to see which were the most effective at predicting lung cancer risk using just three variables – age, how many years the individual smoked for, and the average number of cigarettes per day.

    From these, they selected four model pipelines and combined them into an ‘ensemble’ that was able to predict lung cancer risk with the same or improved accuracy, compared to the best available models currently is use2. Importantly, they were able to achieve this accuracy using only a third of the variables, greatly simplifying the process of gathering the data required.

    Dr Tom Callender (UCL Medicine), first author of the study, said: “Screening for cancer and other diseases saves lives and we are increasingly able to personalise this process. But such personalised screening and disease prevention programmes present important logistical challenges at scale. Our study shows that artificial intelligence can be used to accurately predict lung cancer risk using just three pieces of information that would be easy to gather during routine GP appointments, online or via apps. This approach has the potential to greatly simplify population level screening for lung cancer and help to make it a reality.”

    The models used in the study were externally validated in the US Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial and benchmarked against models that are either in use or have performed strongly in previous analyses. The authors believe the same approach could be viable for simplifying screening process for other diseases, such as type-2 diabetes and cardiovascular disease.

    Professor Mihaela van der Schaar, an author of the study from the University of Cambridge, said: “This research is a prime example of how machine learning tools such as AutoPrognosis, combined with innovative clinical researchers, can make a real impact in healthcare at a population level. While AutoPrognosis has already been applied for risk prediction and prognosis in numerous diseases, this is the first time it has been used to determine the minimal information needed to screen patients. I think this is the future of preventive medicine and I’m optimistic that the same approach could be applied to screening for other diseases.”

    The authors hope the findings will be used to make any national lung cancer screening programme quicker, easier and cheaper to implement, while still achieving the primary aim of reducing lung cancer mortality.

    Professor Sam Janes (UCL Medicine), senior author of the study, said: “It’s great news that the UK is working towards a national screening programme for lung cancer, which remains the leading cause of cancer-related deaths in this country as it does across the world. But as we’ve seen in the US, whose screening programme uptake is just eight per cent, there are hurdles to overcome. For any national screening programme to work, it will need to be feasible to run and succeed in getting people to participate. Our findings are good news on both counts.”

    This work was supported by Wellcome, the National Science Foundation, the Medical Research Council and Cancer Research UK.

    Notes to Editors:

    For more information on lung cancer, see the WHO website.

    The current NHS pilot combines two of the best-performing models available, the US Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial 2012 (PLCOm2012) and Liverpool Lung Project version 2 (LLPv2).

    Publication:

    Thomas Callender et al. ‘Assessing eligibility for lung cancer screening using parsimonious ensemble machine learning models: A development and validation study’ will be published in PLOS Medicine and is strictly embargoed until 3 October 2023 19:00 BST / 14:00 ET.

    DOI: https://doi.org/10.1371/journal.pmed.1004287

    About UCL – London’s Global University

    UCL is a diverse global community of world-class academics, students, industry links, external partners, and alumni. Our powerful collective of individuals and institutions work together to explore new possibilities.

    Since 1826, we have championed independent thought by attracting and nurturing the world’s best minds. Our community of more than 50,000 students from 150 countries and over 16,000 staff pursues academic excellence, breaks boundaries and makes a positive impact on real world problems.

    The Times and Sunday Times University of the Year 2024, we are consistently ranked among the top 10 universities in the world and are one of only a handful of institutions rated as having the strongest academic reputation and the broadest research impact.

    We have a progressive and integrated approach to our teaching and research – championing innovation, creativity and cross-disciplinary working. We teach our students how to think, not what to think, and see them as partners, collaborators and contributors.  

    For almost 200 years, we are proud to have opened higher education to students from a wide range of backgrounds and to change the way we create and share knowledge.

    We were the first in England to welcome women to university education and that courageous attitude and disruptive spirit is still alive today. We are UCL.

    www.ucl.ac.uk | Follow @uclnews on Twitter | Read news at www.ucl.ac.uk/news/ | Listen to UCL podcasts on SoundCloud | View images on Flickr | Find out what’s on at UCL Minds

    [ad_2]

    University College London

    Source link

  • Increased risk of depression and anxiety when in higher education

    Increased risk of depression and anxiety when in higher education

    [ad_1]

    Newswise — Young people who are in higher education in England face a small increased risk of depression and anxiety, compared to their peers who are not attending higher education, finds a new study led by UCL researchers.

    The research paper, published in The Lancet Public Health, is the first to find evidence of higher levels of depression and anxiety among higher education students compared with their peers.

    The authors found that by age 25, the difference had disappeared between graduates and non-graduates.

    Lead author Dr Gemma Lewis (UCL Psychiatry) said: “In recent years in the UK we have seen an increase in mental health problems among young people, so there has been an increased focus on how to support students. Here we have found concerning evidence that students may have a higher risk of depression and anxiety than their peers of the same age who are not in higher education.

    “The first couple of years of higher education are a crucial time for development, so if we could improve the mental health of young people during this time it could have long term benefits for their health and wellbeing, as well as for their educational achievement and longer-term success.”

    The researchers used data from the Longitudinal Studies of Young People in England (LSYPE1 and LSYPE2). The first study included 4,832 young people born in 1989-90, who were aged 18-19 in the years 2007-9. The second study included 6,128 participants born in 1998-99, who were aged 18-19 in the years 2016-18 (i.e., prior to the disruption of the COVID-19 pandemic). In both studies, just over half attended higher education.

    Participants in the studies have completed surveys about their general mental health, to investigate symptoms of depression, anxiety, and social dysfunction, at multiple time points over the years.

    The researchers found a small difference in symptoms of depression and anxiety at age 18-19 between students (including those at university and other higher education institutions) and non-students.

    This association persisted after adjustment for potentially confounding factors including, among others, socioeconomic status, parents’ education, and alcohol use.

    The analysis suggests that if the potential mental health risks of attending higher education were eliminated, the incidence of depression and anxiety could potentially be reduced by 6% among people aged 18-19.

    First author Dr Tayla McCloud (UCL Psychiatry) said: “Based on our findings, we cannot say why students might be more at risk of depression and anxiety than their peers, but it could be related to academic or financial pressure. This increased risk among students has not been found in studies in the past, so if the association has only recently emerged, it may be related to increased financial pressures and worries about achieving high results in the wider economic and social context.

    “We would have expected higher education students to have better mental health than their non-student peers as they tend to be from more privileged backgrounds on average, so these results are particularly concerning. More research is needed to clarify the mental health risks facing students.

    “Improving our understanding of modifiable risk factors for depression and anxiety is a global health priority, and it is clear that supporting the mental health of our young people is vitally important.”

    The study was commissioned and funded by England’s Department for Education.

    Notes to editors

    For more information or to speak to the researchers involved, please contact Chris Lane, UCL Media Relations. T: +44 (0)20 7679 9222 / +44 (0)7717 728 648, E: [email protected]   

    Dr Tayla McCloud; Mr Strahil Kamenov; Prof Claire Callender; Prof Glyn Lewis; Dr Gemma Lewis, ‘The association between higher education attendance and common mental health problems among young people in England: evidence from two population-based cohorts’ will be published in The Lancet Public Health on Thursday 28 September 2023, 23:30 UK time / 18:30 US Eastern time and is under a strict embargo until this time.

    The paper will be published at https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(23)00188-3/fulltext and the DOI will be 10.1016/S2468-2667(23)00188-3.

    Mental health and wellbeing support for UCL students:

    • Prevention is a key competent to mental health and wellbeing support at UCL with a year-round events programme, including workshops on perfectionism, imposter syndrome, importance of sleep and personal safety and activities such as sunrise walks, meditation, laugher workshops and many more, equipping students with the tools to manage their own mental health and wellbeing throughout the evitable highs and lows of student life.
    • All undergraduate first-years are assigned a Student Adviser. Student Advisers sit within the academic department and offer 1-2-1 support for students, to help transition into university life and offer support for wellbeing or student experience matters.  
    • All UCL students can access up to six free sessions of counselling through our Student Psychological and Counselling Services.
    • UCL offers 24/7 free, confidential counselling services in over 35 languages, accessed via UCL’s 24/7 Student Support Line. Students can speak to an adviser who can help through any issues, including but not limited to feeling anxious or stressed, money worries, cultural differences, homesickness, addiction, relationship difficulties, bereavement, bullying, harassment and/or sexual harassment – anything impacting mental health, wellbeing or time at UCL. 
    • The advisers reflect the diverse range of backgrounds needed from our students, with options to speak to a male/female adviser, a BAME adviser or an adviser with additional training in LGBTQ+ related issues. 
    • Current students can also make a same day appointment with UCL’s Support and Wellbeing Team by askUCL or phoning the team directly on +44 (0) 20 3108 8836.
    • More information on our support and wellbeing services available for students: https://www.ucl.ac.uk/students/support-and-wellbeing
    • Report + Support is UCL’s online tool for current and former students and staff to report bullying, harassment and sexual misconduct, and it includes the option to report anonymously or on the record.
    • UCL is one of five universities nationally that qualified for the University Mental Health Charter Award which recognises its commitment to continuous improvement in mental health and wellbeing.

    About UCL – London’s Global University

    UCL is a diverse global community of world-class academics, students, industry links, external partners, and alumni. Our powerful collective of individuals and institutions work together to explore new possibilities.

    Since 1826, we have championed independent thought by attracting and nurturing the world’s best minds. Our community of more than 50,000 students from 150 countries and over 16,000 staff pursues academic excellence, breaks boundaries and makes a positive impact on real world problems.

    The Times and Sunday Times University of the Year 2024, we are consistently ranked among the top 10 universities in the world and are one of only a handful of institutions rated as having the strongest academic reputation and the broadest research impact.

    We have a progressive and integrated approach to our teaching and research – championing innovation, creativity and cross-disciplinary working. We teach our students how to think, not what to think, and see them as partners, collaborators and contributors.  

    For almost 200 years, we are proud to have opened higher education to students from a wide range of backgrounds and to change the way we create and share knowledge.

    We were the first in England to welcome women to university education and that courageous attitude and disruptive spirit is still alive today. We are UCL.

    www.ucl.ac.uk | Follow @uclnews on Twitter | Read news at www.ucl.ac.uk/news/ | Listen to UCL podcasts on SoundCloud | View images on Flickr | Find out what’s on at UCL Minds

    [ad_2]

    University College London

    Source link

  • China’s oldest water pipes were a communal effort

    China’s oldest water pipes were a communal effort

    [ad_1]

    Newswise — A system of ancient ceramic water pipes, the oldest ever unearthed in China, shows that neolithic people were capable of complex engineering feats without the need for a centralised state authority, finds a new study by UCL researchers.

    In a study published in Nature Water, the archaeological team describe a network of ceramic water pipes and drainage ditches at the Chinese walled site of Pingliangtai dating back 4,000 years to a time known as the Longshan period. The network shows cooperation amongst the community to build and maintain the drainage system, though no evidence of a centralised power or authority.

    Dr Yijie Zhuang (UCL Institute of Archaeology), senior and corresponding author on the paper, said: “The discovery of this ceramic water pipe network is remarkable because the people of Pingliangtai were able to build and maintain this advanced water management system with stone age tools and without the organisation of a central power structure. This system would have required a significant level of community-wide planning and coordination, and it was all done communally.”

    The ceramic water pipes make up a drainage system which is the oldest complete system ever discovered in China. Made by interconnecting individual segments, the water pipes run along roads and walls to divert rainwater and show an advanced level of central planning at the neolithic site.

    What’s surprising to researchers is that the settlement of Pingliangtai shows little evidence of social hierarchy. Its houses were uniformly small and show no signs of social stratification or significant inequality amongst the population. Excavations at the town’s cemetery likewise found no evidence of a social hierarchy in burials, a marked difference from excavations at other nearby towns of the same era.

    But, despite the apparent lack of a centralised authority, the town’s population came together and undertook the careful coordination needed to produce the ceramic pipes, plan their layout, install and maintain them, a project which likely took a great deal of effort from much of the community.

    The level of complexity associated with these pipes refutes an earlier understanding in archaeological fields that holds that only a centralised state power with governing elites would be able to muster the organisation and resources to build a complex water management system. While other ancient societies with advanced water systems tended to have a stronger, more centralised governance, or even despotism, Pingliangtai demonstrates that was not always needed, and more egalitarian and communal societies were capable of these kinds of engineering feats as well.

    Co-author Dr Hai Zhang of Peking University said: “Pingliangtai is an extraordinary site. The network of water pipes shows an advanced understanding of engineering and hydrology that was previously only thought possible in more hierarchical societies.”

    Pingliangtai is located in what is now the Huaiyang District of Zhoukou City in central China. During neolithic times, the town was home to about 500 people with protective earthen walls and a surrounding moat. Situated on the Upper Huai River Plain on the vast Huanghuaihai Plain, the area’s climate 4,000 years ago was marked by big seasonal climate shifts, where summer monsoons would commonly dump half a metre of rain on the region monthly.

    Managing these deluges was important to prevent floodwaters from overwhelming the region’s communities. To help mitigate the excessive rainwater during the rainy seasons, the people of Pingliangtai built and operated a two-tier drainage system that was unlike any other seen at the time. They built simple but coordinated lines of drainage ditches that ran parallel to their rows of houses in order to divert water from the residential area to a series of ceramic water pipes that carried the water into the surrounding moat, and away from the village.

    These ceramic water pipes represented an advanced level of technology for the time. While there was some variety in decoration and styles, each pipe segment was about 20 to 30 centimetres in diameter and about 30 to 40 centimetres long. Numerous segments were slotted into each other to transport water over long distances.

    Researchers cannot say specifically how the people of Pingliangtai organised and divided the labour amongst themselves to build and maintain this type of infrastructure. This kind of communal coordination would also have been necessary to build the earthen walls and moat surrounding the village as well. 

    The Pingliangtai drainage system is unique from water systems elsewhere in the world at the time. Its purpose to drain rain and flood water from monsoons differs from other neolithic systems in the world, many of which were used for sewerage water drainage or other purposes.

    Funding was provided by the National Natural Science Foundation of China, the National Natural Science Foundation of China and the Newton Advanced Fellowship of the British Academy.

    [ad_2]

    University College London

    Source link

  • Two in three cosmetic surgery injections in the UK are not administered by doctors

    Two in three cosmetic surgery injections in the UK are not administered by doctors

    [ad_1]

    Newswise — According to an analysis of the UK’s cosmetic injectables industry by UCL researchers, 68% of cosmetic practitioners who are administering injections such as Botox are not qualified medical doctors.

    The study, published in the Journal of Plastic, Reconstructive & Aesthetic Surgery, is the first survey of who is providing cosmetic injectable services, such as Botulinum Toxin (Botox) and Dermal Fillers, in the UK. Currently, little is known about the background qualifications, training and experience levels of those who are administering treatments.

    To fill this knowledge gap, researchers from UCL evaluated 3,000 websites to identify 1,224 independent clinics and 3,667 practitioners who were delivering cosmetic injections such as Botox.

    Of the professions represented, 32% were doctors, 13% were nurses, 24% were dentists and 8% were dental nurses. Of the 1,163 doctors identified, 41% were on the specialist register and 19% were on the GP register. Among the 27 specialties represented on the specialist register, Plastic Surgery was the largest group (37%) followed by Dermatology (18%).

    The UK injectables market is predicted to reach a value of £11.7 billion by 2026, but to date is effectively unregulated. The UK government is preparing to update policy around injectables, with a public consultation on the industry due to begin in August 2023. Recommendations are expected to inform amendments to the Medical Act in 2024.

    Dr David Zargaran (UCL Plastic Surgery), an author of the study, said: “There are well-documented, yet to date unaddressed challenges in the UK cosmetic injectables market. Without knowledge of the professional backgrounds of practitioners, we cannot adequately regulate the industry. Our research highlights that the majority of practitioners are not doctors and include other healthcare professionals, as well as non-healthcare professionals such as beauticians.

    “The range of backgrounds opens a broader question relating to competence and consent. One of the key challenges facing the government’s licensing scheme is to ensure that practitioners granted a licence possess the skills and experience required to safely administer their treatment to minimise risks to patients.

    “It is important for patients to be able to feel comfortable and confident that the person administering their treatment is competent in the procedure as a fundamental foundation of informed consent. This research provides a unique insight into the sector to help inform regulators and patients, and work towards a safer and more transparent cosmetic injectables industry in the UK.”

    As well as the professional background of those providing cosmetic injections, until recently there has been little research on the incidence of complications and the impact that these have upon patients. A second study from the same authors, published on 3 July 2023, found that 69% of respondents to the study had experienced long-lasting adverse effects, such as pain, anxiety and headaches.

    Professor Julie Davies (UCL School Global Business School for Health), a co-author of the study, commented: “The UK cosmetic injectables industry has expanded rapidly in recent years. This has happened largely without scrutiny or oversight. Our findings should be a wake-up call for legislators to implement effective regulation and professional standards to safeguard patients from complications. Although the risks associated with injections are often mild and temporary, the physical complications can be permanent and debilitating. There are also serious psychological, emotional, and financial consequences for patients when procedures go wrong.”

    The work was supported by a research grant from QUAD A.

    Publication:

    David Zargaran et al. ‘Profiling UK injectable aesthetic practitioners: a national cohort analysis’ is published in the Journal of Plastic, Reconstructive & Aesthetic Surgery and is strictly embargoed until 24 July 2023 00:01 GMT / 23 July 19:01 ET

    DOI: https://doi.org/10.1016/j.bjps.2023.06.057

    About UCL – London’s Global University

    UCL is a diverse global community of world-class academics, students, industry links, external partners, and alumni. Our powerful collective of individuals and institutions work together to explore new possibilities.

    Since 1826, we have championed independent thought by attracting and nurturing the world’s best minds. Our community of more than 50,000 students from 150 countries and over 16,000 staff pursues academic excellence, breaks boundaries and makes a positive impact on real world problems.

    We are consistently ranked among the top 10 universities in the world and are one of only a handful of institutions rated as having the strongest academic reputation and the broadest research impact.

    We have a progressive and integrated approach to our teaching and research – championing innovation, creativity and cross-disciplinary working. We teach our students how to think, not what to think, and see them as partners, collaborators and contributors.  

    For almost 200 years, we are proud to have opened higher education to students from a wide range of backgrounds and to change the way we create and share knowledge.

    We were the first in England to welcome women to university education and that courageous attitude and disruptive spirit is still alive today. We are UCL.

    www.ucl.ac.uk | Follow @uclnews on Twitter | Read news at www.ucl.ac.uk/news/ | Listen to UCL podcasts on SoundCloud | Find out what’s on at UCL Minds

    [ad_2]

    University College London

    Source link

  • Giant stone artefacts found on rare Ice Age site in Kent

    Giant stone artefacts found on rare Ice Age site in Kent

    [ad_1]

    Newswise — Researchers at the UCL Institute of Archaeology have discovered some of the largest early prehistoric stone tools in Britain.

    The excavations, which took place in Kent and were commissioned in advance of development of the Maritime Academy School in Frindsbury, revealed prehistoric artefacts in deep Ice Age sediments preserved on a hillside above the Medway Valley.

    The researchers, from UCL Archaeology South-East, discovered 800 stone artefacts thought to be over 300,000 years old, buried in sediments which filled a sinkhole and ancient river channel, outlined in their research, published in Internet Archaeology.

    Amongst the unearthed artefacts were two extremely large flint knives described as “giant handaxes”. Handaxes are stone artefacts which have been chipped, or “knapped,” on both sides to produce a symmetrical shape with a long cutting edge. Researchers believe this type of tool was usually held in the hand and may have been used for butchering animals and cutting meat. The two largest handaxes found at the Maritime site have a distinctive shape with a long and finely worked pointed tip, and a much thicker base.

    Senior Archaeologist Letty Ingrey (UCL Institute of Archaeology), said: “We describe these tools as ‘giants’ when they are over 22cm long and we have two in this size range. The biggest, a colossal 29.5cm in length, is one of the longest ever found in Britain. ‘Giant handaxes’ like this are usually found in the Thames and Medway regions and date from over 300,000 years ago.

    “These handaxes are so big it’s difficult to imagine how they could have been easily held and used. Perhaps they fulfilled a less practical or more symbolic function than other tools, a clear demonstration of strength and skill. While right now, we aren’t sure why such large tools were being made, or which species of early human were making them, this site offers a chance to answer these exciting questions.”

    The site is thought to date to a period in the early prehistory of Britain when Neanderthal people and their cultures were beginning to emerge and may even have shared the landscape with other early human species. The Medway Valley at this time would have been a wild landscape of wooded hills and river valleys, inhabited by red deer and horses, as well as less familiar mammals such as the now-extinct straight-tusked elephant and lion.

    While archaeological finds of this age, including another spectacular ‘giant’ handaxe, have been found in the Medway Valley before, this is the first time they have been found as part of large-scale excavation, offering the opportunity to glean more insights into the lives of their makers.

    Dr Matt Pope (UCL Institute of Archaeology), said: “The excavations at the Maritime Academy have given us an incredibly valuable opportunity to study how an entire Ice Age landscape developed over a quarter of a million years ago. A programme of scientific analysis, involving specialists from UCL and other UK institutions, will now help us to understand why the site was important to ancient people and how the stone artefacts, including the ‘giant handaxes’ helped them adapt to the challenges of Ice Age environments.”

    The research team is now working on identifying and studying the recovered artefacts to better understand who created them and what they were used for.

    Senior Archaeologist Giles Dawkes (UCL Institute of Archaeology) is leading work on a second significant find from the site – a Roman cemetery, dating to at least a quarter of a million years later than the Ice Age activity. The people buried here between the first and fourth centuries AD could have been the inhabitants of a suspected nearby villa that may have lain around 850 metres to the south.

    The team found the remains of 25 individuals, 13 of which were cremated. Nine of the buried individuals were found with goods or personal items including bracelets, and four were interred in wooden coffins. Collections of pottery and animal bones found nearby likely relate to feasting rituals at the time of burial. Though Roman buildings and structures have been extensively excavated, cemeteries have historically been less of a focus for archaeologists and the discovery of this site offers potentially new insights into the burial customs and traditions of both the Romans who lived at the villa, and those in the nearby town of Rochester.

    Jody Murphy, Director of Education at the Thinking Schools Academy Trust said: “We, at Maritime Academy and the Thinking Schools Academy Trust, feel very lucky to be a part of this phenomenal discovery. We take great pride in our connection to our local community and region, with much of our school identity linked to the history of Medway. We look forward to taking advantage of this unique opportunity to teach our young people about these finds, creating a lasting legacy for those who came before us.”

    [ad_2]

    University College London

    Source link

  • Major step forward reduces mortality in kidney failure patients

    Major step forward reduces mortality in kidney failure patients

    [ad_1]

    Newswise — Mortality in patients with kidney failure has been found to be 23% lower among those treated with high dose haemodiafiltration compared to those treated with high flux haemodialysis, according to new research from the CONVINCE consortium led by University Medical Center Utrecht.

    The study, published today in the New England Journal of Medicine, is the first international, randomised trial to compare the two treatments. The findings indicate that wider use of high dose haemodiafiltration would have clear benefits for patients.

    Chronic kidney disease is a leading global health problem that affects an estimated 830 million people globally. When the kidneys can no longer do their job, dialysis is used to clean the blood by removing waste products, a function normally performed by the kidneys themselves. Around four million people are on dialysis worldwide.

    Haemodialysis is the most common form of dialysis used in the treatment for kidney failure1. Though it has improved over the years, it is not good at removing larger molecules from the blood. Haemodiafiltration is a newer technology that can remove larger molecules, but it is not suitable for all patients due to the fact that it requires a higher blood flow rate to be effective. Previous studies have failed to conclusively prove that one method is more effective than the other.

    The CONVINCE trial has been led by researchers at UMC Utrecht together with collaborators at University College London (UCL), Charité Universitätsmedizin Berlin, University of Bari, The George Institute for Global Health and Imperial College London, along with dialysis providers Fresenius Medical Care, Diaverum and B. Braun Avitum. It is the first multinational, randomised trial to compare high-flux haemodialysis and high-dose haemodiafiltration, with the aim of clarifying which method is superior.

    At 61 centres in eight European countries, a total of 1,360 patients were randomised, with 683 treated with high-dose haemodiafiltration and 677 treated with high-flux haemodialysis three times a week.

    During a median follow-up of 30 months, all-cause mortality was 21.9% among those treated with high-flux haemodialysis, compared to 17.3% for those treated with high-volume haemodiafiltration. This 4.6% difference represents a 23% reduction in the risk of death.

    Lead investigator, Professor Peter Blankestijn (UMC Utrecht), said: “Our results show clear survival benefits for using haemodiafiltration over haemodialysis to treat kidney failure, akin to a 23% reduction in all-cause mortality. My hope is that haemodiafiltration can become the new standard.”

    Professor Matthias Rose (Charité University, Berlin), a senior author of the study and expert in patient-reported outcomes, said: “In addition to clinical events, patient perception and thus reported outcomes are very important.  We are currently performing in-depth analyses of the extensive data on patient-reported outcomes that have been collected in the CONVINCE study, with results expected later this year.”

    While haemodialysis is standard treatment in most countries, haemodiafiltration is less widely used in some places and is not used at all in places like the US. Most modern dialysis machines can perform either method, which would make a switch to haemodiafiltration relatively easy.

    Professor Andrew Davenport (UCL Medicine and the Royal Free Hospital), a senior author of the study, said: “During my career I’ve watched new treatments emerge for many diseases, from diabetes to cancer, but we haven’t seen the same advances in the treatment of chronic kidney disease. This study proves that targeting different molecules through haemodiafiltration has clear benefits for patients. I would say that this is the first major step forward in many years and is good news for kidney disease patients and their families.”

    The CONVINCE study was exclusively supported by the European Commission Research & Innovation, Horizon 2020, Call H2020-SC1-2016-2017 under the topic SC1-PM-10-2017: Comparing the effectiveness of existing healthcare interventions in the adult population (grant no 754803).

    [ad_2]

    University College London

    Source link

  • LGB adults at risk of suicide and self-harm

    LGB adults at risk of suicide and self-harm

    [ad_1]

    Newswise — Lesbian, gay and bisexual (LGB) people are more than twice as likely than their straight peers to experience suicidal thoughts or self-harming behaviours, finds a new study led by UCL researchers.

    The study, published in Social Psychiatry and Psychiatric Epidemiology, is the first ever to analyse nationally representative data on sexual orientation and suicidality in England whilst being able to compare individual sexual minority groups. The researchers analysed data combined from two household surveys of 10,443 English adults (aged 16 and over), representative of the population, sampled in 2007 and 2014.

    As well as finding an increased probability of past-year suicidal thoughts among lesbian or gay adults when compared with heterosexuals, and of lifetime non-suicidal self-harm among bisexual, lesbian or gay people, they also found that depression, anxiety, and experiences of discrimination or bullying may contribute in part to these increased risks.

    Concerningly, the researchers found no improvement in these inequalities in suicidal thoughts and self-harm between the two time points.

    Lead author Dr Alexandra Pitman (UCL Psychiatry) said: “While national surveys of British attitudes towards same-sex relationships suggest that society has become more tolerant of people who are gay, lesbian or bisexual, there is clearly a long way to go, as the mental health outcomes we were studying did not improve across our study period.

    “People with sexual minority identities continue to face more discrimination and bullying than heterosexual people and are also more likely to experience common mental health problems such as depression and anxiety. Our study suggests that these experiences of discrimination and bullying may have some role to play in increasing the risk of suicidality and this requires further research.

    “Clinicians should be aware of these issues, so that we can best support the mental health of LGB patients, while society as a whole also has a role to play in helping to reduce discrimination. Government bodies, schools, workplaces and individuals should all consider their own cultures and attitudes towards people from sexual minority groups and challenge discriminatory behaviour.”

    The researchers had previously found, when analysing the same dataset (see note*), an increased probability of depression, anxiety, alcohol misuse and drug misuse among LGB adults compared with their heterosexual peers**. In the current study they found that half of lesbian or gay adults had experienced bullying and one in five had experienced discrimination based on their sexual orientation within the past year. For bisexual adults, almost half had experienced bullying and one in ten had experienced discrimination based on their sexual orientation within the past year.

    The researchers found that even after accounting for the increased risk of common mental health problems (depression and anxiety), lesbian and gay adults were still more than twice as likely as heterosexuals to report past-year suicidal thoughts, and lesbian, gay and bisexual adults were more than three times as likely to report lifetime non-suicidal self-harm than heterosexuals. The findings were similar for both men and women, and these inequalities had not changed between 2007 and 2014.

    When investigating the comparative likelihood of past-year suicide attempt, the researchers found an increased risk for bisexual adults when compared with heterosexuals, but this was no longer apparent when taking into account the increased risk of common mental health problems. The researchers caution that as the proportions with past-year suicide attempt were relatively low, their findings do not necessarily rule out an elevated suicide attempt risk among the sexual minority group as a whole.

    Further analysis suggested that experiences of bullying may contribute to the increased probability of suicidal thoughts among lesbian or gay adults, and that experiences of discrimination and bullying (both categorised as minority stress factors) may each contribute to the increased risk of self-harm among lesbian, gay and bisexual adults.

    First author Garrett Kidd, who worked on the study as his dissertation for a Clinical Mental Health Sciences MSc in UCL Psychiatry, said: “Our findings add to a concerning picture of health inequalities experienced by lesbian, gay and bisexual people.

    “Our health services need to be improved to meet the needs of LGBTQ+ people, as some people may not feel comfortable disclosing their sexual orientation, which can hamper an understanding of their health and social needs. We also need to offer more mental health services specifically catered to LGBTQ+ people, ideally alongside community-based support.”

    The researchers say that further research is needed to fully understand the reasons why sexual minority groups are more likely to experience suicidal thoughts or self-harm, such as how victimisation, family environment or stigma might be contributing factors, and in order to develop public health interventions that could reduce suicidality and potentially save lives.

    The lead researchers were supported by the NIHR University College London Hospitals Biomedical Research Centre.

     

    * The dataset, the Adult Psychiatric Morbidity Survey (APMS) for England, included questions on sexual orientation but not gender identity. The next survey in the APMS series will include questions about gender identity, so that future analyses will be able to look at both gender and sexual identity, and therefore investigate mental health in LGB groups as well as transgender and gender diverse groups.

    ** UCL News, 2021: Mental health disorders and alcohol misuse more common in LGB people. See also evidence that LGB youth are more likely to experience depressive symptoms from as young as age 10 and these symptoms persist at least into their early 20s (UCL News, 2018: Depressive symptoms higher for gay, lesbian and bisexual youth from age 10); the UCL researchers also studied to how reduce LGBTQ+-targeted discrimination and bullying in schools (Video explanationfull study)

    Notes to Editors  

    Garrett Kidd, Louise Marston, Irwin Nazareth, David Osborn, Alexandra Pitman, ‘Suicidal thoughts, suicide attempt and non-suicidal self-harm amongst lesbian, gay and bisexual adults compared with heterosexual adults: analysis of data from two nationally representative English household surveys’ will be published in Social Psychiatry and Psychiatric Epidemiology on Friday 9 June 2023, 00:01 UK time and is under a strict embargo until this time.

    The DOI for this paper will be 10.1007/s00127-023-02490-4.

    Garrett Kidd has also written a blog about the study, which will be published at https://blogs.ucl.ac.uk/mental-health/2023/06/07/examining-the-relationship-between-sexual-orientation-and-suicidality/ (embargoed copy available on request).

    About UCL – London’s Global University

    UCL is a diverse global community of world-class academics, students, industry links, external partners, and alumni. Our powerful collective of individuals and institutions work together to explore new possibilities.

    Since 1826, we have championed independent thought by attracting and nurturing the world’s best minds. Our community of more than 50,000 students from 150 countries and over 16,000 staff pursues academic excellence, breaks boundaries and makes a positive impact on real world problems.

    We are consistently ranked among the top 10 universities in the world and are one of only a handful of institutions rated as having the strongest academic reputation and the broadest research impact.

    We have a progressive and integrated approach to our teaching and research – championing innovation, creativity and cross-disciplinary working. We teach our students how to think, not what to think, and see them as partners, collaborators and contributors.  

    For almost 200 years, we are proud to have opened higher education to students from a wide range of backgrounds and to change the way we create and share knowledge.

    We were the first in England to welcome women to university education and that courageous attitude and disruptive spirit is still alive today. We are UCL.

    www.ucl.ac.uk | Follow @uclnews on Twitter | Read news at www.ucl.ac.uk/news/ | Listen to UCL podcasts on SoundCloud | Find out what’s on at UCL Minds

    [ad_2]

    University College London

    Source link

  • Study reveals unique molecular machinery of woman who can’t feel pain

    Study reveals unique molecular machinery of woman who can’t feel pain

    [ad_1]

    Newswise — The biology underpinning a rare genetic mutation that allows its carrier to live virtually pain-free, heal more rapidly and experience reduced anxiety and fear, has been uncovered by new research from UCL.

    The study, published in Brain, follows up the team’s discovery in 2019 of the FAAH-OUT gene and the rare mutations that cause Jo Cameron to feel virtually no pain and never feel anxious or afraid. The new research describes how the mutation in FAAH-OUT ‘turns down’ FAAH gene expression, as well as the knock-on effects on other molecular pathways linked to wound healing and mood. It is hoped the findings will lead to new drug targets and open up new avenues of research in these areas.

    Jo, who lives in Scotland, was first referred to pain geneticists at UCL in 2013, after her doctor noticed that she experienced no pain after major surgeries on her hip and hand. After six years of searching, they identified a new gene that they named FAAH-OUT, which contained a rare genetic mutation. In combination with another, more common mutation in FAAH, it was found to be the cause of Jo’s unique characteristics.

    The area of the genome containing FAAH-OUT had previously been assumed to be ‘junk’ DNA1 that had no function, but it was found to mediate the expression of FAAH, a gene that is part of the endocannabinoid system and that is well-known for its involvement in pain, mood and memory.

    In this study, the team from UCL sought to understand how FAAH-OUT works at a molecular level, the first step towards being able to take advantage of this unique biology for applications like drug discovery.

    This included a range of approaches, such as CRISPR-Cas9 experiments on cell lines to mimic the effect of the mutation on other genes, as well as analysing the expression of genes to see which were active in molecular pathways involved with pain, mood and healing.

    The team observed that FAAH-OUT regulates the expression of FAAH. When it is significantly turned down as a result of the mutation carried by Jo Cameron, FAAH enzyme activity levels are significantly reduced.

    Dr Andrei Okorokov (UCL Medicine), a senior author of the study, said: “The FAAH-OUT gene is just one small corner of a vast continent, which this study has begun to map. As well as the molecular basis for painlessness, these explorations have identified molecular pathways affecting wound healing and mood, all influenced by the FAAH-OUT mutation. As scientists it is our duty to explore and I think these findings will have important implications for areas of research such as wound healing, depression and more.”

    The authors looked at fibroblasts taken from patients to study the effects of the FAAH-OUT-FAAH axis on other molecular pathways. While the mutations that Jo Cameron carries turn down FAAH, they also found a further 797 genes that were turned up and 348 that were turned down. This included alterations to the WNT pathway that is associated with wound healing, with increased activity in the WNT16 gene that has been previously linked to bone regeneration.

    Two other key genes that were altered were BDNF, which has previously been linked to mood regulation and ACKR3, which helps to regulate opioid levels. These gene changes may contribute to Jo Cameron’s low anxiety, fear and painlessness.

    Professor James Cox (UCL Medicine), a senior author of the study, said: “The initial discovery of the genetic root of Jo Cameron’s unique phenotype was a eureka moment and hugely exciting, but these current findings are where things really start to get interesting. By understanding precisely what is happening at a molecular level, we can start to understand the biology involved and that opens up possibilities for drug discovery that could one day have far-reaching positive impacts for patients.”

    This research was supported by the Medical Research Council (MRC) and Wellcome.

     So called ‘junk’ DNA describes regions of the genome or non-coding genes that don’t create proteins. They were once thought redundant, but in recent years researchers have begun to discover the role of ‘dark’ regions of the genome in regulating coding genes.

    Publication:

    Hajar Mikaeili et al. ‘Molecular basis of FAAH-OUT-associated human pain insensitivity’ will be published in Brain and is strictly embargoed until 24 May 2023 01:01 BST / 23 May 2023 20:01 ET.

    The DOI for this paper will be: https://doi.org/10.1093/brain/awad098

     

    [ad_2]

    University College London

    Source link

  • Researchers identify cause of cancer drug-related heart damage

    Researchers identify cause of cancer drug-related heart damage

    [ad_1]

    Newswise —

    A new study led by researchers from UCL (University College London) has found the likely reason why some cancer treatments can cause damage to the heart. This development brings safer cancer drugs one step closer.

    Modern cancer drugs are effective in treating cancer, but some of them can cause damage to the heart, known as cardiotoxicity. The damage can range from slight changes in the heart’s ability to pump blood to severe heart failure. The exact mechanisms by which these drugs cause damage have not been fully understood so far.

    A new study, supported by the British Heart Foundation, has found certain proteins in the blood that can increase the chances of developing heart diseases, including heart failure. These proteins are also affected by cancer drugs that can cause damage to the heart. The study was published in the journal Science Advances.

    The study found proteins in the blood that are connected to heart diseases and can be affected by cancer drugs, which explains how some cancer treatments damage the heart. By identifying those at risk, better cancer treatments can be developed that avoid affecting these proteins.

    The study has found new possible targets for drugs to treat heart diseases such as heart failure. These drugs could work by stopping proteins that increase the risk of developing heart diseases or by activating proteins that lower the risk.

    To begin their research, the scientists conducted a study called genome-wide association. This involved analyzing the DNA of almost 37,000 individuals who did not have heart disease and were part of the UK Biobank study. Through this analysis, they identified genetic variations that were associated with changes in the ventricles, which are the heart’s pumping chambers.

    Our genes have instructions to make proteins, which are important for the body. By analyzing the DNA of almost 37,000 people without heart disease, researchers found 33 proteins linked to the risk of developing different heart diseases. These proteins are present in the blood and are coded for by genetic variants. Some of these proteins are also targeted by cancer drugs.

    Dr. Floriaan Schmidt, the lead author from UCL Institute of Cardiovascular Science, said that the proteins identified in the study can help in developing new drugs for cancer and heart diseases. The findings can provide a blueprint for drug development, making scientists more confident in designing drugs that can shrink tumors without causing damage to the heart or improve the heart’s pumping action.

    Professor Sir Nilesh Samani from the British Heart Foundation has said that although there have been advancements in cancer treatment, there is a risk of heart damage caused by some cancer drugs.

    Professor Sir Nilesh Samani explained that this study has paved the way for the development of safer and more targeted drugs, reducing the risk of heart problems after cancer treatment. He believes that this research can help to make worries about heart damage after cancer treatment a thing of the past.

    This research was also supported by the UKRI/NIHR Multimorbidity fund Mechanism and Therapeutics Research Collaborative and the Rosetrees Trust.

    [ad_2]

    University College London

    Source link

  • Genetic code of hornets sequenced to understand their successful invasion

    Genetic code of hornets sequenced to understand their successful invasion

    [ad_1]

    Newswise — The genomes of two hornet species, the European hornet and the Asian hornet (or yellow-legged hornet) have been sequenced for the first time by a team led by UCL (University College London) scientists.

    By comparing these decoded genomes with that of the giant northern hornet, which has recently been sequenced by another team, the researchers have revealed clues suggesting why hornets have been so successful as invasive species across the globe.

    Hornets are the largest of the social wasps; they play important ecological roles as top predators of other insects. In their native regions, they are natural pest controllers, helping regulate the populations of insects such as flies, beetles, caterpillars and other types of wasps. These services are critical for healthy, functional ecosystems, as well as for agriculture.

    But hornets also tend to be very successful as invasive species. They can become established in areas they are not native to and cause potentially huge ecological and economic damage by hunting important pollinators, such as honeybees, wild bees and hoverflies.

    To better understand how these species have so successfully expanded their ranges, the international team of scientists investigated the genomes of three types of hornets.

    A genome sequence is the set of instructions – a genetic code – that makes a species. Comparing the genomes of different species can give insights into their biology – their behaviour, evolution, and how they interact with the environment.

    The researchers have newly sequenced the genomes of the native European hornet, Vespa crabro – an important top predator, which is protected in parts of Europe – and the invasive yellow-legged Asian hornet Vespa velutina, which has become established through much of Europe over the last 20 years threatening native ecosystems, and has occasionally been sighted in the UK. They compared these with the genome of the giant northern hornet, Vespa mandarinia – a species known for its role as pest controller, pollinator and food provider in its native Asian range, but is a recent arrival in North America, where it may threaten native fauna.

    By analysing differences between the three related species, the researchers were able to identify genes that have been rapidly evolving since the species differentiated themselves from other wasps and from one another, and found some noteworthy genes that are rapidly evolving, particularly relating to communication and olfaction (smell).

    The study’s first author, Dr Emeline Favreau (UCL Centre for Biodiversity & Environment), said: “We were excited to find evidence of rapid genome evolution in these hornet genomes, compared to other social insects. Lots of genes have been duplicated or mutated; these included genes that are likely to be involved in communication and in sensing the environment.”

    Genome evolution allows organisms to adapt to their environment and make the most of their surroundings by developing new behaviours and physiology.

    Co-author Dr Alessandro Cini, who began the work at UCL before moving to the University of Pisa, said: “These findings are exciting, as they may help explain why hornets have been so successful in establishing new populations in non-native regions.

    “Hornets are carried to different parts of the world accidentally by humans. All that is needed is a small number of mated queens to be transported, hidden in cargo perhaps. The genomes suggest that hornets have lots of genes involved in detecting and responding to chemical cues – these may make them especially good at adapting to hunt different types of prey in non-native regions.”

    Senior author Professor Seirian Sumner (UCL Centre for Biodiversity & Environment) said: “These hornet genomes are just the beginning. The genomes of more than 3,000 insect species have now been sequenced by efforts around the world, but wasps are under-represented among these.

    “Genomes tell us about aspects of the ecology and evolution that other methods cannot. Evolution has equipped these insects with an incredible genetic toolbox with which to exploit their environment and hunt their prey.”

    Armed with these new genomes, the scientists hope to help improve the management of hornet populations, both for their ecosystem services as pest controllers in native zones, and as ecological threats in regions where they are invasive.

    The study involved researchers in the UK, Italy, Spain, Israel, France, New Zealand, and Austria, and was primarily funded by the Natural Environment Research Council.

    [ad_2]

    University College London

    Source link

  • Comparing airfares instead of seat size fairer indicator of passenger carbon emissions

    Comparing airfares instead of seat size fairer indicator of passenger carbon emissions

    [ad_1]

    Newswise — Allocating passenger aircraft emissions using airfares rather than travel class would give a more accurate idea of individual contributions, finds a study led by UCL.

    Emissions calculators base their estimates on travel class, assuming that someone travelling in a higher class and therefore taking up more space on the plane is responsible for more emissions.

    The study, published in Environmental Research Letters, describes how including airfares in calculations shows which passengers contribute the most revenue to the airline operating the aircraft, thereby allowing the plane to fly.

    Although in general, premium (business) seats are more expensive than economy, the researchers found when looking at data that many late bookings in economy class, often made for business trips or by high income travellers, cost as much as, or more than, premium seats.

    Lead author Dr Stijn van Ewijk (UCL Civil, Environmental & Geomatic Engineering) said: “The paper shows we should follow the money when calculating emissions of individual travellers, as it is revenue that decides whether an airline can operate a plane or not. Someone who has paid twice as much as a fellow traveller contributes twice as much to the revenue of the airline and should be allocated twice the emissions. The seat size of each travel class, which is currently used to allocate emissions, is only a rough approximation of how much passengers pay.”

    The researchers say that using airfares to calculate passenger emissions would benefit efforts to address climate change by encouraging people on all budgets to find alternative modes of transport where possible. It would also increase estimates of corporate emissions because it allocates more to expensive late bookings, which are often made for business purposes.

    Implementing a tax that is proportionate to the price of the ticket could make the total costs of flying fairer. People buying the most expensive tickets would pay the highest tax, encouraging them to seek alternatives.

    Whilst taxes differ between countries, typically the rates are the same across each travel class. Travellers buying expensive tickets, who are more likely to have higher incomes, pay a relatively low tax and are not currently discouraged from flying.

    Dr Van Ewijk added: “An equitable approach to reducing airline emissions should not just deter travellers who can only afford the cheapest early bookings but also the big spenders who bankroll the airline. By assigning emissions based on ticket prices, and taxing those emissions, we can make sure everyone pays their fair share, and is equally encouraged to look for alternatives.”

    A ticket tax should also take into account the distance flown and the model and age of plane, which can indicate how polluting it is.

    The authors used a dataset from the USA to test their fare-based allocation approach. They used the Airline Origin Survey database, which includes ticket fare data, origin and destination, travel class and fare per mile. From this, they calculated the distribution of ticket prices across all passengers on a typical flight.

    Based on the price distribution, the authors allocated emissions to passengers, and compared the results with estimates from widely used emissions calculators. Since ticket prices vary strongly by time of booking, the emissions per passenger varied too, far more than on the basis of seat size and travel class.

    Using an economic supply–demand model, the researchers estimated how a carbon tax on emissions would affect travellers, depending on whether the emissions the tax applied to were calculated from seat size and travel class, or the airfare. In all scenarios, a tax on emissions calculated from airfares had a more equitable effect because it reduced flying more evenly across income groups.

    The researchers hope to effect policy change in calculating and taxing passenger emissions, to ensure travellers on all budgets are encouraged to seek other forms of transport where possible or consider how essential the journey is.

     

    Notes to Editors

    Stijn van Ewijk, Shitiz Chaudhary, Peter Berrill; Estimating passenger emissions from airfares supports equitable climate action will be published in Environmental Research Letters on Wednesday 25th January, 12:00 UK time, 07:00 ET and is under a strict embargo until this time.

    The DOI for this paper will be 10.1088/1748-9326/acaa48

    Additional material

    Graphs and figures from the paper

    Credit: Dr Stijn Van Ewijk

    [ad_2]

    University College London

    Source link

  • I’m Sorry, but This COVID Policy Is Ridiculous

    I’m Sorry, but This COVID Policy Is Ridiculous

    [ad_1]

    Cases have surged in China since it dropped its zero-COVID policy in December, and the latest models now suggest that at least 1 million people may die as a result. Many countries have responded by policing their borders: Last week, the CDC announced that anyone entering the United States from China would be required to test negative within two days of departure; the U.K., Canada, and Australia quickly followed suit; and the European Union has urged its member states to do the same. (Taking a more extreme tack, Morocco has said it will ban travelers from China from entering altogether.) At a media briefing on Wednesday, World Health Organization Director-General Tedros Adhanom Ghebreyesus said, “It is understandable that some countries are taking steps they believe will protect their own citizens.”

    On Tuesday, a Chinese official denounced some of the new restrictions as having “no scientific basis.” She wasn’t wrong. If the goal is to “slow the spread of COVID” from overseas, as the CDC has stated, there is little evidence to suggest that the restrictions will be effective. More important, it wouldn’t matter if they were: COVID is already spreading unchecked in the U.S. and many of the other countries that have new rules in place, so imported cases wouldn’t make much of a difference. The risk is particularly low given the fact that 95 percent of China’s locally acquired cases are being caused by two Omicron lineages—BA.5.2 and BF.7—that are old news elsewhere. “The most dangerous new variant at the moment is from New York—XBB.1.5—which the U.S. is now busy exporting to the rest of the world,” Christina Pagel, a mathematician who studies health care at University College London, told me. “I’m sorry, but this is fucking ridiculous.”

    By now, it’s well known that travel restrictions can’t stop COVID from crossing borders. At best, they slow its entry. When Omicron was first detected, in South Africa in late November 2021, America blocked travel from southern-African countries in an attempt to prevent the variant from spreading; by mid-December, Omicron dominated the United States. Restrictions can delay the spread of a variant only if they are implemented while cases are low and before travelers have had a chance to spread it. Such policies were more effective early in the pandemic: A BMJ Global Health review concluded that the initial ban on all travel into or out of Wuhan, China, in January 2020 significantly reduced the number of cases exported to other countries and delayed outbreaks elsewhere by “up to a few weeks.” Later on, such restrictions lost value. The COVID Border Accountability Project, which tracks travel restrictions around the world, has found that border closures did not reduce COVID spread, at least through April 2021, Mary Shiraef, the project’s principal investigator and a political scientist at Notre Dame University, told me. (According to the study, domestic lockdowns did slow transmission.)

    At this stage of the pandemic, restrictions make sense only under two conditions, Pagel said: The country deploying them must have low levels of spread and good control policies, and the restrictions must be applied to all other nations, as opposed to just one. Neither of these conditions is being met right now by any country deploying travel measures against China. Even if a single-point ban did serve some useful purpose, the rules in place for China don’t add up. Predeparture testing likely won’t catch most infected travelers from China, Adam Kucharski, a professor of infectious-disease epidemiology at the London School of Hygiene and Tropical Medicine, told me. A person could test negative one day and then positive a few days later. If the point of restrictions is to slow local transmission, Kucharski said, calculations based on his research suggest that travelers should be tested twice: once before they arrive, then about three or four days afterward. Doing so would catch infected travelers who initially tested negative while limiting their window for spreading disease.

    The best possible outcome of a travel restriction like the one the U.S. now has in place would be a very small delay before the arrival of a catastrophic new variant that has just emerged in China. In that scenario, any extra time might be used to intensify mitigation strategies and assess the degree to which current vaccines are expected to hold up. Historically, though, the time saved by travel bans has been wasted. After countries restricted travel from South Africa to keep Omicron at bay, governments responded by “not really doing much at all domestically,” Kucharski said. In any case, as my colleague Katherine J. Wu has pointed out, the virus is able to spread easily in China right now without any further changes to its genome. Population immunity there is modest, owing to the country’s low natural-infection rate and less effective vaccines, so the virus can infect people perfectly well as is.

    The travel restrictions on China will have little impact on the spread of COVID, but they do send a forceful political message. The U.S. measures are meant to pressure China, by slowing its economic rebound, into being transparent about its COVID situation, Stephen Morrison, the director of the Global Health Policy Center at the Center for Strategic and International Studies, a Washington, D.C.-based think tank, told me. China’s alleged official death count, for example—5,259 as of January 4—seems way too low to be believable, especially amid reports of overflowing Chinese hospitals and funeral homes. So long as the country isn’t more forthcoming, Morrison said, then Chinese tourists, who have only recently been allowed to travel internationally, will continue to be unwelcome.

    Expressing this message through a largely pointless public-health measure comes with a price. When that measure fails to keep COVID spread at bay, faith in public-health institutions could decline, which Pagel said is the “biggest danger” for the next pandemic. It also stokes the long-standing fear that Chinese people are more likely to carry disease than anyone else, whether foreign or American. “We are watching this policy so carefully to see if it will once again invite a racial backlash,” Manjusha Kulkarni, a co-founder of Stop AAPI Hate, told me. If a rise in anti-Asian hate and violence comes along with more transparency from China about its COVID situation, the cost of these restrictions hardly seems worth their benefits.

    [ad_2]

    Yasmin Tayag

    Source link

  • Brain area necessary for fluid intelligence identified

    Brain area necessary for fluid intelligence identified

    [ad_1]

    Newswise — A team led by UCL and UCLH researchers have mapped the parts of the brain that support our ability to solve problems without prior experience – otherwise known as fluid intelligence.

    Fluid intelligence is arguably the defining feature of human cognition. It predicts educational and professional success, social mobility, health, and longevity. It also correlates with many cognitive abilities such as memory.

    Fluid intelligence is thought to be a key feature involved in “active thinking” – a set of complex mental processes such as those involved in abstraction, judgment, attention, strategy generation and inhibition. These skills can all be used in everyday activities – from organising a dinner party to filling out a tax return.

    Despite its central role in human behaviour, fluid intelligence remains contentious, with regards to whether it is a single or a cluster of cognitive abilities, and the nature of its relationship with the brain.

    To establish which parts of the brain are necessary for a certain ability, researchers must study patients in whom that part is either missing or damaged. Such “lesion-deficit mapping” studies are difficult to conduct owing to the challenge of identifying and testing patients with focal brain injury.

    Consequently, previous studies have mainly used functional imaging (fMRI) techniques – which can be misleading.

    The new study, led by UCL Queen Square Institute of Neurology and National Hospital for Neurology and Neurosurgery at UCLH researchers and published in Brain, investigated 227 patients who had suffered either a brain tumour or stroke to specific parts of the brain, using the Raven Advanced Progressive Matrices (APM): the best-established test of fluid intelligence. The test contains multiple choice visual pattern problems of increasing difficulty. Each problem presents an incomplete pattern of geometric figures and requires selection of the missing piece from a set of multiple possible choices.

    The researchers then introduced a novel “lesion-deficit mapping” approach to disentangle the intricate anatomical patterns of common forms of brain injury, such as stroke.

    Their approach treated the relations between brain regions as a mathematical network whose connections describe the tendency of regions to be affected together, either because of the disease process or in reflection of common cognitive ability.

    This enabled researchers to disentangle the brain map of cognitive abilities from the patterns of damage – allowing them to map the different parts of the brain and determine which patients did worse in the fluid intelligence task according to their injuries.

    The researchers found that fluid intelligence impaired performance was largely confined to patients with right frontal lesions – rather than a wide set of regions distributed across the brain. Alongside brain tumours and stroke, such damage is often found in patients with a range of other neurological conditions, including traumatic brain injury and dementia.

    Lead author, Professor Lisa Cipolotti (UCL Queen Square Institute of Neurology), said: “Our findings indicate for the first time that the right frontal regions of the brain are critical to the high-level functions involved in fluid intelligence, such as problem solving and reasoning.

    “This supports the use of APM in a clinical setting, as a way of assessing fluid intelligence and identifying right frontal lobe dysfunction.

    “Our approach of combining novel lesion-deficit mapping with detailed investigation of APM performance in a large sample of patients provides crucial information about the neural basis of fluid intelligence. More attention to lesion studies is essential to uncover the relationship between the brain and cognition, which often determines how neurological disorders are treated.”

    The study was funded by Welcome and the NIHR UCLH Biomedical Research Centre funding scheme. Researchers also received funding from The National Brain Appeal and the Guarantors of Brain.

    [ad_2]

    University College London

    Source link

  • Pandemic Babies’ Microbiomes Are Bound to Be Different

    Pandemic Babies’ Microbiomes Are Bound to Be Different

    [ad_1]

    In the spring of 2021, Brett Finlay, a microbiologist at the University of British Columbia, offered the world a bold and worrying prediction. “My guess is that five years from now we are going to see a bolus of kids with asthma and obesity,” he told Wired. Those children, he said, would be “the COVID kids”: those born just before or during the height of the crisis, when the coronavirus was everywhere, and we cleaned everything because we didn’t want it to be.

    Finlay’s forecast isn’t unfounded. As James Hamblin wrote in The Atlantic last year, our health relies on a constant discourse with trillions of microbes that live on or inside our bodies. The members of the so-called microbiome are crucial for digesting our food, training the immune system, even greasing the wheels of cognitive function; there does not seem to be a bodily system that these tiny tenants do not in some way affect. These microbe-human dialogues begin in infancy, and the first three or so years of life are absolutely pivotal: Bacteria must colonize babies, then the two parties need to get into physiological sync. Major disruptions during this time “can throw the system out of whack,” says Katherine Amato, a biological anthropologist at Northwestern University, and raise a kid’s risk of developing allergies, asthma, obesity, and other chronic conditions later in life.

    The earlier, more intense, and more prolonged the interruptions, the worse. Infants who receive heavy courses of antibiotics—which can nuke microbial diversity—are at greater risk of developing such problems; the same is roughly true for babies who are born by C-section, who formula feed, or who grow up in nature-poor environments. If pandemic-era mitigations re-create even an echo of those effects, that could spell trouble for a whole lot of little kids who may have lost out on beneficial microbes in the ongoing effort to keep nasty ones at bay.

    More than a year and a half after Finlay’s original prediction, children are back in day care and school. People no longer keep their distance or avoid big crowds. Even hygiene theater is (mostly) on the wane. And if the wave of respiratory viral illness now slamming much of the Northern Hemisphere is any indication, microbes are once again swirling between tiny hands and mouths. But for the circa-COVID kids, the specter of 2026 and Finlay’s anticipated chronic-illness “bump” still looms—and it’ll be a good while yet before researchers have clarity on just how much of a difference those months of relative microbial emptiness truly made.

    For now, “we are in the realm of speculation,” says Maria Gloria Dominguez Bello, a microbiologist at Rutgers. Scientists don’t understand how, or even which, behaviors may affect the composition of our inner flora throughout our life span. Chronic illnesses such as obesity and asthma also take time to manifest. There’s not yet evidence that they’re on the rise among children, and even if they were, researchers wouldn’t expect to see the signal for at least a couple of years, perhaps more.

    Finlay, for one, stands by his original prediction that the pandemic will bring a net microbiome negative. “We underwent a massive societal shift,” he told me. “I am sure we will see an effect.” And he is not the only one who thinks so. “I think it’s almost inevitable that there has been an impact,” says Graham Rook, a medical microbiologist at University College London. If the middle of this decade passes without incident, Rook told me, “I would be very surprised.” Other researchers, though, aren’t so sure. “I don’t think we have doomed a generation of kids,” says Melissa Manus, an anthropologist and microbiome researcher at the University of Manitoba. A few scientists are even pondering whether the pandemic’s ripple effects may have buoyed the microbiomes of the COVID kids. Martin Blaser, a microbiologist at Rutgers University, told me that, “with any luck,” rates of asthma and obesity might even dip in the next few years.

    When it comes to the pandemic’s potential fallout, researchers agree on just one thing: COVID babies undoubtedly had an unusual infancy; on average, their microbiomes are bound to look quite different. Different, though, isn’t necessarily bad. “It’s not like there is one golden microbiome,” says Efrem Lim, a microbiologist at Arizona State University. Take Liz Johnson’s sons, born in March 2018, August 2020, and March 2022. All three were born vaginally, in the same hospital, with the assistance of the same midwife; all of them then breastfed; and none of them has undergone an early, concerning antibiotic course. And still, “they all started off with different microbiomes,” she told me. (As a microbiome researcher at Cornell focused on infant nutrition, Johnson can check.)

    That’s probably totally fine. Across the human population, microbiomes are known to vary wildly: People can carry hundreds of bacterial species on and inside their bodies, with potentially zero overlap from one individual to the next. Bacterial communities aren’t unlike recipes—if you don’t have one ingredient on hand, another can usually take its place.

    Johnson’s middle son, Lucas, had a starkly different birth experience from that of his older brother—even, in many ways, from that of his younger brother. Lucas was born into a delivery room full of masked faces. In the days after his arrival, no family members came to visit him in the hospital. And although his brothers spent several of their early months jet-setting all around the world with their mother for work trips, Lucas stayed put. “Hardly anybody even knew he was born,” Johnson told me. But throughout his first two years, Lucas still breastfed and had plenty of contact with his family at home, as well as with other kids at day care; he romped in green spaces galore. Yet Johnson and others can’t say, precisely, whether all of that outweighs the sanitariness and the uncrowdedness of Lucas’s earliest days. There would have been a cost to both overcaution and under-caution, “so we just tried to balance everything,” Johnson said. When it comes down to it, scientists just don’t know how much microbial exposure constitutes enough.

    Among COVID babies, microbiome mileage will probably vary, depending on what decisions their parents made at the height of the pandemic—which itself hinges on the sorts of financial and social resources they had. Amato worries most about the families that may have packaged a bunch of sanitizing behaviors together with more established cullers of microbiome diversity: C-sections, formula-feeding, and antibiotic use. Meghan Azad, an infant-health researcher at the University of Manitoba, told me that some new parents might have found it far tougher to breastfeed during the pandemic’s worst—a time when in-person counseling resources were harder to access, and employment was in flux. Chronically poor diets and stress, which many people experienced these past few years, can also chip away at microbiome health.

    Part of the problem is that many of these risk factors, Rook told me, will disproportionately coalesce among people of lower socioeconomic status, who already tend to have less diverse microbiomes. “I worry this will further increase the health disparity between the rich and the poor,” he said. Even SARS-CoV-2 infections themselves, which have continued to concentrate among essential workers and in crowded living settings, appear to alter the microbiome—a shift that may be temporary in adults, but potentially less so in infants, whose microbiomes haven’t yet matured into a stable state.

    Many families exist in a gray zone. Maybe they bleached their households often, but found it easier to breastfeed and cook healthful meals while working from home. Maybe their kids weren’t mingling with tons of other toddlers at day care, but they spent much more time rolling around in the backyard, coated in their pandemic puppy’s drool. If all of those factors feed into an equation that sums up to healthy or not, scientists can’t yet do the math. They’re still figuring out how to appropriately weigh each component, and how to identify others they’ve missed.

    Even in the absence of extra outdoorsiness or dog slobber, Lim isn’t very concerned about the behavioral mitigations people picked up. We’re all “exposed to thousands of microbes all the time,” Lim, who has a 1-and-a-half-year-old daughter, told me. Some extra hand-washing, masking, and time at home is nothing compared with, say, an antibiotic blitzkrieg. Even kids who stayed pretty cloistered “were not living in a bubble.” Some of the social sacrifices kids made may even have strange silver linings. Children no longer attending day care or preschool might have skirted a whole slew of other viral infections that would otherwise have gotten them inappropriate and microbiome-damaging antibiotics prescriptions. Antibiotic use in outpatient settings dropped substantially in 2020, compared with the prior year. Stacked up against the relatively minor toll of pandemic mitigations, Blaser told me, the plus of avoiding antibiotics might just win out. When antibiotic use declines, for example, so do asthma rates.

    Finlay and others are still keeping an eye out for signals that might start to appear in the next few years. Perhaps most at risk are kids whose families went into “hyper-hygiene mode” in the first couple months of their life, when microbes are crucial for properly calibrating the immune system’s anti-pathogen alarms. Miss out on those opportunities, and our body’s defensive cells might end up mistaking enemies for allies, or vice versa, sparking particularly severe infections or autoimmune disease. Once wired into a developing child, Finlay said, such changes might be difficult to reverse, especially for the youngest of the COVID cohort. But other experts are hopeful that certain microbial losses can still be recouped through some combination of diet, outdoor play, and socialization (with people who aren’t sick)—restorative interventions that, ideally, happen as early as possible. “The sooner we fix it, the better,” Blaser said.

    No one can choose precisely which microbes to be exposed to: Tactics that halt the transmission of known pathogens have a way of halting the transmission of benign bugs too. But context matters. It’s possible for microbe-inviting behaviors, such as outdoor play, to coexist alongside microbe-shunning tactics, such as ventilating indoor spaces when there’s a massive respiratory outbreak. The fact that we can influence microbial colonization at all is powerful. During the pandemic, mitigations that kept COVID at bay also cratered rates of flu and RSV. Now that those viruses are back, experts are pointing out that we already know how they can once again be stopped. And the choices that people made, and continue to make, to protect their families from pathogens shouldn’t be viewed as some harmful mistake, says Ariangela Kozik, a microbiologist at the University of Michigan.

    Pandemic kids can get on board with that concept too. Kozik’s now-7-year-old son was a toddler when the pandemic began; even amid society’s hygiene craze, he learned the joys of tumbling around in the dirt and playing with the family’s two dogs. “We talk about how not all germs are the same,” Kozik told me. Her son also picked up and maintained an infection-quashing habit that makes his mom proud: Every day, when he comes home from school, he makes a beeline for the sink to wash his hands. “It’s the first thing he does,” Kozik told me, “even without being asked.”

    [ad_2]

    Katherine J. Wu

    Source link

  • Symptoms of long Covid in children may change over time

    Symptoms of long Covid in children may change over time

    [ad_1]

    New symptoms may appear in children up to a year after initial infection with Covid-19, finds a new study led by UCL researchers.

    The Children and young people with Long Covid (CLoCk) study, published in The Lancet Regional Health – Europe, is the world’s largest study on long Covid in children.

    Researchers asked children aged 11 to 17 about their health six months and 12 months after taking a PCR test between September 2020 and March 2021. They also asked them to recall their symptoms at the time of taking the test.

    None of the children initially invited to participate in the study had been hospitalised. In total the researchers examined data from 5,086 children, 2,909 of whom tested positive for Covid-19, and 2,177 of whom tested negative.

    Researchers asked the children and young people what they had experienced from a list of 21 symptoms, including shortness of breath and tiredness, as well as using validated scales to assess quality of life, mental health, wellbeing and fatigue.

    The team found that, at time of testing, health issues were more common in children and young people who had tested positive for the virus compared to those who tested negative, as well as six months and 12 months post PCR test. For example, among the test-positives, 10.9% reported fatigue at all three time points while among test-negatives only 1.2% reported fatigue at all three time points.

    They also noted that the symptoms experienced changed over the course of a year. And while some of the children’s original symptoms declined, new symptoms were reported (see Figure).

    This was also the case when researchers looked at scales measuring poor quality of life, experiencing emotional and behavioural difficulties, poor wellbeing and fatigue.

    As a result, the researchers have found that the symptoms of long Covid experienced by children and young people change over time and that clinicians should be aware of this.

    Corresponding author, Dr Snehal Pinto Pereira (UCL Surgery & Interventional Science) said: “Our research goes one step further than existing studies and indicates that researchers need to track individual trajectories using repeated measurement on the same children and young people over time.

    “Simply reporting repeated cross-sectional prevalences – or snapshots – of symptoms over time may obscure important information about long Covid in young people that has clinical relevance.”

    The CLoCK study is one of four major studies funded by NIHR and UKRI to help improve understanding of the causes, symptoms and treatment of the longer-term effects of Covid-19 in people who have not become unwell enough to be admitted to hospital.

    The team, led by Professor Sir Terence Stephenson (UCL Great Ormond Street Institute of Child Health), was awarded £1.36 million for the study looking into long Covid in 11- to 17-year-olds.

    The landmark study will continue to analyse survey results from participants for up to two years after the initial PCR test.

    The study involves collaboration with researchers at the universities of Edinburgh, Bristol, Oxford, Cambridge, Liverpool, Leicester, Manchester as well as King’s College London, Imperial College London, UK Health Security Agency, Great Ormond Street Hospital and University College London Hospitals (UCLH).

    Study Limitations

    The symptoms reported by participants at time of testing are subject to recall bias as they were reported at the time of first contact with the CloCk study (at either three months or six months post-test). However, six-month and 12-month symptoms were reported at the time they were being experienced.

    Original PCR tests were taken before the Delta and Omicron variants became dominant, so the findings may not reflect the long-term effects of these variants.

    Children and young people self-reported their symptoms. In some instances, such as to assess shortness of breath, it may have been better to conduct in-person medical interviews. However this was not feasible or practical during the study period.

    The researchers removed data from children who tested positive (by PCR or lateral flow test) after the initial PCR test from the analysis, to ensure that those in the test-negative group had not had Covid-19 across the study period, although they cannot rule out the possibility that some children in either group may have subsequently been infected without it being detected.

    Notes to Editors

    Figure Prevalence of shortness of breath and tiredness in test-positives and test-negatives by time when they were first reported

     

    Snehal Pinto Pereira, Roz Shafran, Manjula Nugawela, Laura Panagi, Dougal Hargreaves, Shamez Ladhani, Sophie Bennett, Trudie Chalder, Emma Dalrymple, Tasmin Ford, Isobel Heyman, Kelsey McOwat, Natalia Rojas, Kishan Sharma, Ruth Simmons, Simon White, Terence Stephenson. Natural course of health and well-being in non-hospitalised children and young people after testing from SARS-CoV-2: a prospective and follow-up study over 12 months, will be published in The Lancet Regional Health – Europe, on Monday 5th December 2022 at 05:00 UK time / 00:00 ET.

    [ad_2]

    University College London

    Source link

  • Personalising whole genome sequencing doubles diagnosis of rare diseases

    Personalising whole genome sequencing doubles diagnosis of rare diseases

    [ad_1]

    Newswise — Tailoring the analysis of whole genome sequencing to individual patients could double the diagnostic rates of rare diseases, finds a new study led by UCL researchers.

    In 2018, the UK’s department of health announced an NHS Genomic Medicine Service, which allows patients with rare diseases to have their entire genetic code read in the hope of providing a much-needed diagnosis.

    However, the interpretation of this data can be extremely challenging and many people with complex, rare genetic diseases still do not receive a molecular answer to the cause of their problems.

    In the study, published in Nature Communications, researchers at The London Mitochondrial Centre at UCL Queen Square Institute of Neurology and UCL Great Ormond Street Institute of Child Health sought to offer such patients an improved chance of receiving a genetic diagnosis.

    To do so, they tested how using a genomic medicine team of specialist doctors, bioinformaticians, and scientists could boost the capabilities of NHS diagnostic laboratories beyond the standard semi-automated analysis of data. The UCL team re-evaluated undiagnosed cases to identify clues that might help direct further, more personalised analysis. They subsequently applied additional bioinformatic approaches, using advanced computer technologies to identify genetic alterations in a patients’ DNA which may be causing disease but had been overlooked during routine testing.

    The work included 102 undiagnosed patients, suspected of having a primary mitochondrial disease (a large group of incurable genetic disorders that affect children and adults, associated with a broad spectrum of medical problems, severe disabilities, and reduced lifespan), who had undergone whole genome sequencing via the NHS’s 100,000 Genomes Project.

    This personalised approach increased the diagnostic rate from 16.7% to 31.4%. It also detected potential disease-causing variants in a further 3.9% of patients.

    Lead author, Dr Robert Pitceathly (co-lead for the London NHS Highly Specialised Service for Rare Mitochondrial Disorders and a research group leader at UCL Queen Square Institute of Neurology), said: “The NHS has invested heavily in advanced genetic technologies. Consequently, the UK has established itself at the forefront of diagnostic whole genome sequencing. That said, some people with rare genetic diseases remain without a molecular diagnosis after their genome is analysed.

    “We believe investing in specialist genomic medicine teams is crucial, ensuring equitable access to dedicated multidisciplinary expertise and maximising diagnoses. On average, patients in our study waited over 30 years for a diagnosis – we now have the capability to solve such cases but need adequate workforce planning to support NHS diagnostic genetic laboratories in achieving this goal.”

    Receiving a genetic diagnosis is important as it allows patients to receive access to family planning, specialised IVF, and drugs trials. It can also permit targeted screening of known disease complications and access to drug studies.

    Dr Pitceathly said: “In this study, every new genetic diagnosis had a direct impact on patient care. This included additional check-ups for heart problems, hearing loss, and diabetes, and access to clinical trials.”

    Professor Michael Hanna, Director of UCL Queen Square Institute of Neurology said: “This work is a significant step forward in developing the best ways to maximise the benefits of genome analysis for patients. It clearly demonstrates that by combining automated approaches to genome analysis with data interpretation by a skilled multidisciplinary team the diagnostic rates doubles. This is an important finding that will influence how genomic medicine diagnostic services should evolve world-wide.”

    Co-author, Dr James Davison (Metabolic Medicine Department at Great Ormond Street Hospital and chair of the British Inherited Metabolic Diseases Group), said: “The journey to reaching a diagnosis for children and adults with rare, complex, medical conditions can be a very long process, and genomic medicine provides a transformative and powerful tool in helping reach that goal.

    “This study highlights the importance of the collaboration between specialist clinicians and genetic scientists in interpreting the results of genome sequencing to maximise the opportunity of reaching a diagnosis which can then help guide medical management and treatment options.”

    The researchers involved in this study are funded by the Medical Research Council.

    Patient story

    Rachel North was one of the patients involved in the trial and described getting a diagnosis as “life changing”. It has since allowed her to be screened for disease complications such as osteopenia, and these have been treated.

    She said: “I had attended so many hospitals over the past 20 years and had been searching so long, I never thought I’d get a diagnosis.

    “Wondering about it took up so much energy, and I was worried about my 12-year-old son, and if my condition would affect him. So, getting a rare recessive diagnosis was a relief and takes away fear of the unknown.

    “Having a diagnosis allows me to research my condition and be very proactive in managing it.

    “Anything that helps me understand and make sense of what is happening to my body helps me come to terms with it and gives me confidence that I am managing it as well as possible.”

    Notes to Editors

     

    William L. Macken, Micol Falabella, Caroline McKittrick, Chiara Pizzamiglio, Rebecca Ellmers, Kelly Eggleton, Cathy E. Woodward, Yogan Patel, Robyn Labrum, Genomics England Research Consortium, Rahul Phadke, Mary M. Reilly, Catherine DeVile, Anna Sarkozy, Emma Footitt, James Davison, Shamima Rahman, Henry Houlden, Enrico Bugiardini, Rosaline Quinlivan, Michael G. Hanna, Jana Vandrovcova, Robert D. S. Pitceathly. Specialist multidisciplinary input maximises rare disease diagnoses from whole genome sequencing, will be published in Nature Communications, on 7th November 2022 at 10:00 GMT / 05:00 ET.

     

    The DOI for this paper will be: 10.1038/s41467-022-32908-7

    [ad_2]

    University College London

    Source link

  • Lumiii Partners with University College London’s EdTech Labs to Fundamentally Reshape Education Through Its Learn-to-Earn Gaming and Anime Series

    Lumiii Partners with University College London’s EdTech Labs to Fundamentally Reshape Education Through Its Learn-to-Earn Gaming and Anime Series

    [ad_1]

    In this partnership, Lumiii will apply UCL EdTech Labs’ research-focused method, expert mentoring, and community knowledge to its storytelling.

    Press Release


    Jun 7, 2022

    Secret Pirates Entertainment Inc., creators of The Secret Order of Lumiiis franchise, announces Lumiii has partnered with University College London’s (UCL) EdTech Labs Accelerator, a learning innovations program for world-leading products as one of the program’s first American startups. The strategic partnership will synergize Lumiii’s entertainment, gaming, and family DeFi offerings with UCL’s 50-plus years of experience in developing robust, impactful, and commercially viable products.

    “Our children will grow up in a vastly different world than previous generations with technology that we can’t even imagine today,” said Ali Badshah, co-president, CEO, and creator of the Lumiiis franchise. “Our partnership with UCL EdTech Labs Accelerator will help us bring Lumiii to the estimated two billion learners emerging over the next 30 years.”

    UCL EdTech Labs accelerator program launches in America with its first cohort of startups, and Lumiii has been recognized as one of the most exciting edtech products. Lumiii offers innovative digital education crafted along with the goals of UN Sustainable Development: Zero Hunger, Gender Equality, No Poverty, and more. 

    “UCL Edtech Labs is delighted to be partnering with the team at Lumiii,” said Houtan Froushan, UCL EdTech Labs Program Director. “We expanded into the Americas in search of the world’s brightest and best edtech innovators — and that is exactly what we’ve found in Lumiii and their phenomenally talented team.” 

    Lumiii incentivizes users to learn the UN SDGs, Web3 essentials, and the World Economic Forum’s Future-Needed Job Skills, in exchange for LumiiiTokens and premium LumiiiNFT gaming products.

    “Our partnership will place the learner at the heart of the learning products Lumiii is building. Applying our evidence-based innovation methods developed with some of the greatest minds around, coupled with the wonderful creators at Lumiii, can only result in some of the most exciting educational products out there,” added Froushan.

    To learn more, visit https://lumiiis.newswiremap.com.

    About Secret Pirates Entertainment Inc.

    Secret Pirates Entertainment Inc. is a Canadian global media and gaming company marketing consumer products across all age groups. Founded in 2021 by Ali Badshah and Mehdi Rahman, Secret Pirates’ mandate is to democratize the global arts and entertainment industry through altruism and decentralized technologies.

    About Lumiii

    Lumiii uses interactive storytelling and learn-to-earn gaming to build the next generation of skilled and conscientious people. Co-founded by ACTRA Award-nominated actor, showrunner, and comedian Ali Badshah and international business leader Mehdi Rahman, Lumiii by Secret Pirates Entertainment Inc. demystifies the blockchain and decentralized finance (DeFi) for kids and adults, while amplifying the United Nations’ Sustainable Development Goals (UN SDGs) through its entertainment, gaming, and easy-to-use digital offerings.

    To learn more about Lumiii, visit Lumiii.com.

    About UCL EdTech Labs

    UCL EdTech Labs is a UCL-led programme that connects the learning innovations community to the world’s best educational research and entrepreneurial practice, developing and growing the brightest learning and teaching innovators whose visions are to fundamentally reshape how people learn. Its pioneering approach aims to build and develop world-class EdTech products and services, based on what works for teachers and learners. Enabling entrepreneurs to develop and grow, creating the very best products that are tried and tested with the learner at the heart. UCL ETtech Labs is supported by Santander Universities, AWS, OneValley and IDEALondon, and is in an alliance with University College London. For further information, visit www.UCLedtechlabs.com.

    Media Contact 

    Madeleine Moench
    madeleine@newswire.com 

    Source: Lumiii

    [ad_2]

    Source link